A new artificial intelligence (AI) model developed by scientists has the potential to revolutionise tuberculosis (TB) treatment by predicting personalised treatment outcomes. Published in the journal iScience, the study analysed diverse biomedical data from TB patients, including clinical tests, genomics, medical imaging, and drug prescriptions.